Development and therapeutic perspectives of CXCR4 antagonists for disease therapy

Area of Science:

• Biochemistry
• Pharmacology
• Molecular Biology

Background:

• Chemokine receptor 4 (CXCR4), a GPCR family member, is implicated in HIV-1 infection, cancer, and inflammation.
• Its involvement in various diseases makes CXCR4 a significant target for therapeutic intervention.
• Current CXCR4 antagonist clinical trials primarily utilize peptides and antibodies, with limited small molecule exploration.

Purpose of the Study:

• To review the structure-activity relationship (SAR) of CXCR4 antagonists.
• To explore CXCR4's role in disease pathogenesis and its binding interactions.
• To propose strategies for enhancing the efficacy of CXCR4-targeting drugs.

Main Methods:

• Literature review focusing on CXCR4 structure-activity relationships.
• Analysis of existing CXCR4 antagonists, including small molecules, peptides, and antibodies.
• Exploration of disease-specific CXCR4 binding characteristics and modification strategies.

Main Results:

• Detailed discussion of SAR for various CXCR4 antagonists.
• Identification of common structural features and target interactions.
• Overview of modification approaches for optimizing drug effectiveness.

Conclusions:

• CXCR4 antagonists hold significant therapeutic potential across multiple disease areas.
• Understanding SAR is crucial for designing effective CXCR4-targeting drugs.
• Further research into modification strategies could lead to improved drug candidates.